Interferon-induced Remission in Aggressive Fibromatosis of the Lower Extremity

By Fernberg Jan-Olof   Brosjö Otte   Larsson Olle   Söderlund Veli   Strander Hans  

Acta Oncologica, Vol. 38, Iss. 7, 1999-11 ,pp. : 971-972

Informa Healthcare

Access to resources Recommend Favorite

Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature

By Wcislo Gabriel   Szarlej-Wcislo Katarzyna   Szczylik Cezary  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 8, 2007-08 ,pp. : 533-538

Springer Publishing Company

Access to resources Recommend Favorite

Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature

By      

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 325-328

Spandidos Publications

Access to resources Recommend Favorite

Susceptibility of fibromatosis cells in short-term culture to ifosfamide: a possible experimental treatment in clinically aggressive cases

By Verrill Mark W.   Coley Helen M.   Judson Ian R.   Fisher Cyril  

Sarcoma, Vol. 3, Iss. 2, 1999-09 ,pp. : 79-84

Informa Healthcare

Access to resources Recommend Favorite

An association between the 4G polymorphism in the PAI-1 promoter and the development of aggressive fibromatosis (desmoid tumor) in familial adenomatous polyposis patients

By Li Catherine   Wei Robert   Baliko Frank   Bapat Bharati   Alman Benjamin  

Familial Cancer, Vol. 6, Iss. 1, 2007-03 ,pp. : 89-95

Springer Publishing Company

Access to resources Recommend Favorite